We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$6.8B
AUM Growth
+$947M
Cap. Flow
+$838M
Cap. Flow %
12.32%
Top 10 Hldgs %
21.42%
Holding
2,018
New
252
Increased
1,012
Reduced
601
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 4.99%
2 Financials 4.82%
3 Healthcare 4.39%
4 Industrials 4.19%
5 Consumer Staples 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
1901
Westport Fuel Systems
WPRT
$35.7M
$25K ﹤0.01%
+1,064
New +$16.6K
ORKA
1902
Oruka Therapeutics
ORKA
$5.96B
$25K ﹤0.01%
48
REFR icon
1903
Research Frontiers
REFR
$17M
$23K ﹤0.01%
17,700
-4,600
-21% -$5.78K
UQM
1904
DELISTED
UQM Technologies, Inc.
UQM
$22K ﹤0.01%
+26,114
New +$17.8K
TURN
1905
DELISTED
180 Degree Capital
TURN
$21K ﹤0.01%
+4,308
New +$19.8K
ATHX
1906
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
560
PLM
1907
DELISTED
PolyMet Mining Corp.
PLM
$20K ﹤0.01%
3,359
EGY icon
1908
Vaalco Energy
EGY
$594M
$19K ﹤0.01%
19,855
-275
-1% -$270
ARWR icon
1909
Arrowhead Research
ARWR
$12.4B
$17K ﹤0.01%
10,600
NAVB
1910
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$17K ﹤0.01%
1,641
+3
+0.2% +$30
BAC.WS.B
1911
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$16K ﹤0.01%
+20,000
New +$14.6K
PGH
1912
DELISTED
Pengrowth Energy Corporation
PGH
$15K ﹤0.01%
19,249
+465
+2% +$424
NVCN
1913
DELISTED
Neovasc Inc.
NVCN
0
HHS icon
1914
Harte-Hanks
HHS
$12K ﹤0.01%
1,200
ASXC
1915
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
1,135
HEPA
1916
DELISTED
Hepion Pharmaceuticals
HEPA
0
XTNT icon
1917
Xtant Medical Holdings
XTNT
$62.3M
$8K ﹤0.01%
1,067
-500
-32% -$3.33K
BXE
1918
DELISTED
Bellatrix Exploration Ltd.
BXE
$6K ﹤0.01%
+2,000
New +$6.97K
GAZ
1919
DELISTED
iPath Bloomberg Natural Gas Subindex Total Return ETN due October 22, 2037
GAZ
$4K ﹤0.01%
11,622
-400
-3% -$155
ADEA icon
1920
Adeia
ADEA
$3.11B
-23,217
Closed -$209K
ADNT icon
1921
Adient
ADNT
$1.5B
-2,968
Closed -$216K
AG icon
1922
First Majestic Silver
AG
$9.07B
-12,500
Closed -$102K
ARCB icon
1923
ArcBest
ARCB
$3.08B
-11,194
Closed -$291K
ASPS icon
1924
Altisource Portfolio Solutions
ASPS
$65.8M
-1,453
Closed -$428K
AUB icon
1925
Atlantic Union Bankshares
AUB
$5.97B
-6,317
Closed -$222K

Similar funds

Cambridge Investment Research Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Cambridge Investment Research Advisors held 2,018 positions worth $6.8B, up 16% from $5.85B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $838M of net new capital in Q2 2017, opening 252 new positions and adding to 1,012 existing holdings. Its largest new stake was Apple: 3,555,600 shares worth $128M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Financials ETF, an estimated $9.78M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2017 buy was Apple: 3,555,600 shares worth $128M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $24M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2017 reduction was iShares US Financials ETF, cutting an estimated $9.78M.
  • Cambridge Investment Research Advisors fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $3.81M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $6.8B portfolio in Q2 2017.
  • Cambridge Investment Research Advisors opened 252 new positions and closed 90 in Q2 2017.
  • Cambridge Investment Research Advisors's portfolio value rose 16% quarter-over-quarter to $6.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2017, filed 8 Aug 2017.